Zydus Lifesci.

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "989.40",
    "chg": 50.15,
    "chgp": "5.34%",
    "dir": 1,
    "prev_price": "939.25",
    "mcapval": "99,556.79 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE010B01027",
    "curr_date": "May 14",
    "curr_time": "",
    "bse_nse_vol": "33.4 lacs",
    "exc_status": "Active",
    "traded_date": "May 14, 2026",
    "traded_date_str": "2026 05 14",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Lifesciences Ltd Rallies 5.15% and Approaches Key Moving Averages — Momentum Builds",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-intraday-high-with-515-surge-on-14-may-2026-3991255",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_priceRelatedfactors_3991255.png",
        "date": "2026-05-14 11:16:01",
        "description": "The Sensex remained flat on 14 Jun 2026, but Zydus Lifesciences Ltd surged 5.15%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 3.9 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly subdued market environment."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-bullish-momentum-3991211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_3991211.png",
        "date": "2026-05-14 11:00:06",
        "description": "Zydus Lifesciences Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector peers with a 4.81% gain on 14 May 2026, supported by rising volumes and positive price action, prompting a recent upgrade in its Mojo Grade from Sell to Hold."
      },
      {
        "title": "Zydus Lifesciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-valuation-3988846",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_mojoScore_3988846.png",
        "date": "2026-05-13 08:18:48",
        "description": "Zydus Lifesciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across key parameters including quality, valuation, financial trends, and technical indicators. This shift comes amid a backdrop of mixed quarterly results but strong long-term fundamentals and improved market positioning."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3988490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_technicaldot_3988490.png",
        "date": "2026-05-13 08:01:17",
        "description": "Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a day-on-day price decline of 2.71%, the stock’s weekly and monthly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-volatile-trading-3987592",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_3987592.png",
        "date": "2026-05-12 12:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 12.19% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite underperforming its sector and the broader Sensex, the surge in open interest combined with elevated volatility and rising delivery volumes suggests evolving directional bets among traders."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3987538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_3987538.png",
        "date": "2026-05-12 11:00:07",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 12.3% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3987106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_3987106.png",
        "date": "2026-05-12 10:00:07",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 11.57% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Zydus Lifesciences Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-valuation-shifts-from-attractive-to-fair-amid-sector-dynamics-3978630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_valuationdot_3978630.png",
        "date": "2026-05-07 08:00:39",
        "description": "Zydus Lifesciences Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of December 2025. This change reflects evolving market perceptions amid a competitive Pharmaceuticals & Biotechnology sector, with key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a moderation in price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-3973338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_mojoScore_3973338.png",
        "date": "2026-05-04 10:10:03",
        "description": "Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 652,
    "sid": "290229",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding Disclosure of Consolidated Related Party Transactions for the half year ended on September 30, 2019.",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 05, 2019, titled \"Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "03-Dec-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "19 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>1100%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zydus Lifesciences Ltd Rallies 5.15% and Approaches Key Moving Averages — Momentum Builds

2026-05-14 11:16:01

The Sensex remained flat on 14 Jun 2026, but Zydus Lifesciences Ltd surged 5.15%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 3.9 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly subdued market environment.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum

2026-05-14 11:00:06

Zydus Lifesciences Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector peers with a 4.81% gain on 14 May 2026, supported by rising volumes and positive price action, prompting a recent upgrade in its Mojo Grade from Sell to Hold.

Read full news article

Zydus Lifesciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation

2026-05-13 08:18:48

Zydus Lifesciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across key parameters including quality, valuation, financial trends, and technical indicators. This shift comes amid a backdrop of mixed quarterly results but strong long-term fundamentals and improved market positioning.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-13 08:01:17

Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a day-on-day price decline of 2.71%, the stock’s weekly and monthly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Volatile Trading

2026-05-12 12:00:08

Zydus Lifesciences Ltd has witnessed a notable 12.19% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite underperforming its sector and the broader Sensex, the surge in open interest combined with elevated volatility and rising delivery volumes suggests evolving directional bets among traders.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-05-12 11:00:07

Zydus Lifesciences Ltd has witnessed a notable 12.3% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-05-12 10:00:07

Zydus Lifesciences Ltd has witnessed a notable 11.57% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Zydus Lifesciences Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics

2026-05-07 08:00:39

Zydus Lifesciences Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of December 2025. This change reflects evolving market perceptions amid a competitive Pharmaceuticals & Biotechnology sector, with key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a moderation in price attractiveness relative to historical and peer benchmarks.

Read full news article

Zydus Lifesciences Ltd is Rated Sell

2026-05-04 10:10:03

Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News